CONNECT WITH US
HealthTech

HealthTech

Suki debuts agentic operating system

Healthcare Dive logo

Published on

Add as a preferred source on Google
Suki debuts agentic operating system

The AI scribe company is taking a platform approach and a wider lens on healthcare workflows beyond clinical care as it seeks to stand out in a competitive market of health AI vendors.

Suki is best known for its ambient clinical documentation tool that transcribes doctor-patient interactions. It has also expanded into clinical decision-making support and automated medical coding. Now, the company is taking a wider lens into healthcare workflows beyond clinical care as it seeks to stand out in a competitive market of health AI vendors.

The new operating system is designed to make it easier for healthcare organizations to integrate AI solutions without replacing existing systems, according to the announcement. The company plans to extend its features to health tech partners building on its platform in the future.

“Effectively, Suki OS now adds an agentic layer to the whole Suki product suite, which allows us to finish the last mile of whatever has to be done as a result of that doctor-patient encounter,” Soni said.

With the operating system, Suki touts the system’s ability to support clinicians by preparing patient summaries before appointments, while connected agents verify insurance, facilitate prior authorizations and reduce overall administrative burden throughout an interaction with a patient.

Its two new agents will play a key role in that, according to the announcement, with a pointed focus on advancing prior authorization and revenue cycle workflows.

Suki also launched a framework that ties the success of its product to its own financial viability. In an unconventional move, the company is offering customers their Suki fees back if agreed-upon performance outcomes are not reached.


Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.